PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 25, 2013Journal of Medicinal Chemistry32 citations

Do Medicinal Chemists Learn from Activity Cliffs? A Systematic Evaluation of Cliff Progression in Evolving Compound Data Sets

View Full Paper
DDDilyana DimovaKHKathrin HeikampDSDagmar Stumpfe

Key Points

Key points are not available for this paper at this time.

Abstract

Activity cliffs are defined as pairs of structurally similar compounds with a significant difference in potency. These compound pairs have high SAR information content because they represent small structural changes leading to large potency alterations. Accordingly, activity cliffs are of prime interest for SAR exploration and compound optimization. It is currently unknown to what extent activity cliff information is utilized in practical medicinal chemistry. Therefore, we have assembled 56 compound data sets that evolved over time and searched for analogues of activity cliff-forming compounds with further increased potency. For ∼75% of all activity cliffs, there was no evidence for further chemical exploration. For ∼25% of all cliffs, potency progression was detected. In total, for ∼15% of all activity cliffs, positive cliff progression was observed that often involved multiple analogues. Given these findings, chemically unexplored activity cliffs should provide significant opportunities for further study in medicinal chemistry.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Dimova et al. (2013) studied this question.

synapsesocial.com/papers/6a230b1f9135d99b72cb2736https://doi.org/10.1021/jm400147j
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MMP-Cliffs: Systematic Identification of Activity Cliffs on the Basis of Matched Molecular Pairs2012 · 214 citations
  2. 2Frequency of Occurrence and Potency Range Distribution of Activity Cliffs in Bioactive Compounds2012 · 29 citations
  3. 3On Outliers and Activity CliffsWhy QSAR Often Disappoints2006 · 738 citations
  4. 4Chemoinformatics in Drug Discovery2005 · 269 citations
  5. 5ChEMBL: a large-scale bioactivity database for drug discovery2011 · 4,567 citations